CytoDyn Inc.
CytoDyn Inc. (CYDY) Company Profile & Overview
Explore CytoDyn Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
CytoDyn Inc. (CYDY) Company Profile & Overview
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as coronavirus disease (COVID-19). It is also conducting a Phase 1b/2 clinical trial with leronlimab in metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.